Ranked by reported Q1 2026 13F market value
Share of total reported institutional value in MCRB held by the largest 10 / 25 filers.
| # | Institution | Shares Held | Market Value | QoQ Change | Ownership % | % of Fund |
|---|---|---|---|---|---|---|
| 1 | Flagship Pioneering Inc. | 1.2M | $10.3M | 0.0% | 12.000% | 0.88% |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | 294K | $2.6M | β | 3.054% | 0.00% |
| 3 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 227K | $2.0M | -31.8% | 2.356% | 0.00% |
| 4 | MARSHALL WACE, LLP | 140K | $1.2M | +16.1% | 1.449% | 0.00% |
| 5 | Vontobel Holding Ltd. | 138K | $1.2M | +34.1% | 1.438% | 0.00% |
| 6 | BlackRock, Inc. | 102K | $905K | -1.5% | 1.059% | 0.00% |
| 7 | GEODE CAPITAL MANAGEMENT, LLC | 75K | $664K | -13.1% | 0.777% | 0.00% |
| 8 | AMERICAN CENTURY COMPANIES INC | 62K | $553K | +283.0% | 0.647% | 0.00% |
| 9 | VANGUARD FIDUCIARY TRUST CO | 40K | $352K | β | 0.412% | 0.00% |
| 10 | STATE STREET CORP | 34K | $301K | 0.0% | 0.352% | 0.00% |
| 11 | CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 32K | $281K | +0.8% | 0.328% | 0.00% |
| 12 | Lion Point Capital, LP | 32K | $280K | 0.0% | 0.328% | 1.67% |
| 13 | MORGAN STANLEY | 22K | $192K | -13.6% | 0.225% | 0.00% |
| 14 | TWO SIGMA INVESTMENTS, LP | 19K | $167K | -27.0% | 0.195% | 0.00% |
| 15 | NORTHERN TRUST CORP | 15K | $131K | 0.0% | 0.153% | 0.00% |
| 16 | Invesco Ltd. | 15K | $129K | +1.3% | 0.151% | 0.00% |
| 17 | Marex Group plc | 100K | $95K | β | 1.038% | 0.00% |
| 18 | UBS Group AG | 7K | $62K | +66.3% | 0.073% | 0.00% |
| 19 | BARCLAYS PLC | 7K | $58K | -12.4% | 0.068% | 0.00% |
| 20 | SBI Securities Co., Ltd. | 3K | $31K | 0.0% | 0.036% | 0.00% |
| 21 | SIMPLEX TRADING, LLC | 3K | $27K | +149.2% | 0.032% | 0.00% |
| 22 | Vanguard Global Advisers, LLC | 2K | $18K | β | 0.021% | 0.00% |
| 23 | FMR LLC | 2K | $16K | +0.7% | 0.018% | 0.00% |
| 24 | Rachor Investment Advisory Services, LLC | 1K | $13K | 0.0% | 0.015% | 0.01% |
| 25 | GROUP ONE TRADING, L.P. | 824 | $7K | β | 0.009% | 0.00% |
denotes a marquee investor (Buffett, Burry, ARK, Tiger Global, Pershing Square, Baupost and other widely-followed managers). β% of Fundβ shows how much of that investorβs total 13F portfolio is invested in MCRB β a direct measure of their conviction.
Filings activity in MCRB during Q1 2026, grouped by how each filer changed its position.
8 quarters of 13F filings Β· Ξ columns show change vs prior quarter
| Quarter | Inst. Holders | Ξ Holders | Ownership % | Ξ Ownership | Total 13F Value | Ξ Value |
|---|---|---|---|---|---|---|
| Q1 2026 | 34 | 5.6% | 39.40% | 32.15 pp | $22M | 45% |
| Q4 2025 | 36 | +16% | 71.55% | 3.94 pp | $39M | 5.2% |
| Q3 2025 | 31 | 6.1% | 75.49% | +27.22 pp | $41M | +56% |
| Q2 2025 | 33 | 48% | 48.27% | 30.20 pp | $27M | 38% |
| Q1 2025 | 64 | 7.2% | 78.47% | 21.11 pp | $43M | 21% |
| Q4 2024 | 69 | 10% | 99.58% | 100.41 pp | $55M | 82% |
| Q3 2024 | 77 | 18% | 199.99% | +107.56 pp | $296M | +482% |
| Q2 2024 | 94 | β | 92.43% | β | $51M | β |
Source: SEC 13F institutional filings. Ownership % requires market cap data and will show once linked. Ξ columns compare to the immediately prior filed quarter.
Quick answers to the most common questions about buying MCRB stock.
Based on Q1 2026 13F filings, institutional ownership of Seres Therapeutics, Inc. stands at 39.4%, held across 34 reporting institutions.
Flagship Pioneering Inc. is the largest reported institutional holder of MCRB, with approximately 1,155,850 shares worth $0.01B as of Q1 2026.
Yes β 2 widely-followed marquee investors appear among the top 25 institutional holders of MCRB, including SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA INVESTMENTS, LP.
Our composite Smart Money Score for MCRB is 39 out of 100 (Bearish). It combines net institutional buying activity, ownership shift, marquee investor presence, and holder-count growth.
6 institutions opened new positions in MCRB during Q1 2026, while 8 fully exited. 2 added to existing positions and 25 trimmed.
MCRB institutional ownership fell by 32.15 percentage points quarter-over-quarter, with a net change of -2 holders.
The top 10 institutions account for 93.0% of all reported 13F value in MCRB, and the top 25 account for 99.9%.
All data is sourced from SEC Form 13F filings, which institutional investment managers with at least $100M in assets are required to file each quarter. We process every 13F filing from EDGAR and recompute the aggregates after each cycle. Insider transactions are sourced from Form 4 filings.
Seres Therapeutics, Inc. (MCRB) Institutional Ownership